tirzepatide tachycardia Should a patient with stop taking (glucagon-like peptide-1 (GLP-1) receptor agonist)? Tirzepatide and Cardiovascular Outcomes: A

Radwan RM, Lee YA, Kotecha P, Wright DR, Hernandez I, Ramon R, et al

Several of the methods that work for panic attacks could also be useful for anxiety attacks

For microdosing specifically, oral formulations present challenges

Gastrointestinal symptoms are the most common adverse effects of GLP-1 medications

Minimal criteria for the histological diagnosis of definite NASH included the combined presence of grade 1 steatosis, hepatocyte ballooning, and lobular inflammation with or without fibrosis

Our program may also include hormonal balancing, gut health regulation, nutritional guidance, lifestyle coaching, and even post-weight-loss skin tightening treatments